1
|
Perez V, Zaobornyj T, Vico T, Vanasco V, Marchini T, Godoy E, Alvarez S, Evelson P, Donato M, Gelpi RJ, D'Annunzio V. Middle-age abolishes cardioprotection conferred by thioredoxin-1 in mice. Arch Biochem Biophys 2024; 753:109880. [PMID: 38171410 DOI: 10.1016/j.abb.2023.109880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Revised: 12/29/2023] [Accepted: 12/30/2023] [Indexed: 01/05/2024]
Abstract
Thioredoxin-1 (Trx1) has cardioprotective effects on ischemia/reperfusion (I/R) injury, although its role in ischemic postconditioning (PostC) in middle-aged mice is not understood. This study aimed to evaluate if combining two cardioprotective strategies, such as Trx1 overexpression and PostC, could exert a synergistic effect in reducing infarct size in middle-aged mice. Young or middle-aged wild-type mice (Wt), transgenic mice overexpressing Trx1, and dominant negative (DN-Trx1) mutant of Trx1 mice were used. Mice hearts were subjected to I/R or PostC protocol. Infarct size, hydrogen peroxide (H2O2) production, protein nitration, Trx1 activity, mitochondrial function, and Trx1, pAkt and pGSK3β expression were measured. PostC could not reduce infarct size even in the presence of Trx1 overexpression in middle-aged mice. This finding was accompanied by a lack of Akt and GSK3β phosphorylation, and Trx1 expression (in Wt group). Trx1 activity was diminished and H2O2 production and protein nitration were increased in middle-age. The respiratory control rate dropped after I/R in Wt-Young and PostC restored this value, but not in middle-aged groups. Our results showed that Trx1 plays a key role in the PostC protection mechanism in young but not middle-aged mice, even in the presence of Trx1 overexpression.
Collapse
Affiliation(s)
- V Perez
- Universidad de Buenos Aires, Facultad de Ciencias Médicas, Departamento de Patología - Institute of Cardiovascular Physiopathology, Argentina
| | - T Zaobornyj
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Institute of Biochemistry and Molecular Medicine (IBIMOL UBA-CONICET), Argentina
| | - T Vico
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Institute of Biochemistry and Molecular Medicine (IBIMOL UBA-CONICET), Argentina
| | - V Vanasco
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Institute of Biochemistry and Molecular Medicine (IBIMOL UBA-CONICET), Argentina
| | - T Marchini
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Institute of Biochemistry and Molecular Medicine (IBIMOL UBA-CONICET), Argentina
| | - E Godoy
- Universidad de Buenos Aires, Facultad de Ciencias Médicas, Departamento de Patología - Institute of Cardiovascular Physiopathology, Argentina
| | - S Alvarez
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Institute of Biochemistry and Molecular Medicine (IBIMOL UBA-CONICET), Argentina
| | - P Evelson
- Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Institute of Biochemistry and Molecular Medicine (IBIMOL UBA-CONICET), Argentina
| | - M Donato
- Universidad de Buenos Aires, Facultad de Ciencias Médicas, Departamento de Patología - Institute of Cardiovascular Physiopathology, Argentina
| | - R J Gelpi
- Universidad de Buenos Aires, Facultad de Ciencias Médicas, Departamento de Patología - Institute of Cardiovascular Physiopathology, Argentina
| | - V D'Annunzio
- Universidad de Buenos Aires, Facultad de Ciencias Médicas, Departamento de Patología - Institute of Cardiovascular Physiopathology, Argentina.
| |
Collapse
|
2
|
Läubli H, Alonso G, Lopez J, Calvo E, Joerger M, Perez V, Di Blasi D, Nair A, Richter K, Huber C, Mouton J, Costanzo S, Jethwa S, Bucher C, Garralda E. 749P ANV419, a selective IL-2R-beta-gamma targeted antibody-IL-2 fusion protein, in patients with advanced solid tumors, a phase I/II study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
3
|
Zapico D, Espinosa J, Criado M, Fernández M, Ferreras M, Benavides J, Perez V. Local Assessment of the Immunohistochemical Expression of Foxp3+ Regulatory T Lymphocytes in the Different Pathological Forms Associated with Bovine Paratuberculosis. J Comp Pathol 2022. [DOI: 10.1016/j.jcpa.2021.11.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Muñoz-Montaño W, De la Garza-Ramos C, Tabares A, Cabrera-Galeana P, Perez V, Porras Reyes F, Sanchez Benitez D, Olvera A, Alvarado-Miranda A, Lara-Medina F, Mohar Betancourt A, Bargallo-Rocha E, Vazquez-Romo R, Arrieta O, Villarreal-Garza C. 216P The impact of pregnancy-associated breast cancer (PABC) according to immunohistochemical (IHC) subtype: A matched case-control study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
5
|
Bénard S, Roche N, Garcia G, De Larrard A, Cancalon C, Vieu L, Mahieu A, Perez V, Demoly P. Impact en vie réelle de l’asthme sévère non contrôlé en France sur la mortalité et les consommations de soins des patients âgés de 12 ans et plus–Étude RESONANCE. Rev Epidemiol Sante Publique 2020. [DOI: 10.1016/j.respe.2020.04.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
6
|
Romera I, Perez V, Menchón J, Delgado-Cohen H, Polavieja P, Gilaberte I. Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study. Eur Psychiatry 2020; 25:58-65. [DOI: 10.1016/j.eurpsy.2009.02.007] [Citation(s) in RCA: 58] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2008] [Revised: 12/30/2008] [Accepted: 02/19/2009] [Indexed: 11/28/2022] Open
Abstract
AbstractPurposeTo evaluate social and occupational functioning in patients in partial remission (PR) compared with patients in complete remission (CR) of a major depressive disorder (MDD) episode.Subjects and methodsThis is a six-month prospective study. PR was defined as a score more than 7 and less or equal to 15 in the Hamilton Depression Rating Scale, and CR as less or equal to 7. All patients had been on acute antidepressant treatment during the previous three months and no longer met criteria for MDD. Functioning was assessed by the Social and Occupational Functioning Assessment Scale (SOFAS).ResultsMean (S.D.) patient age was 50.5 (14.5) years (N = 292) and 77% were female. At baseline, partial remitters showed greater impairment in social and occupational functioning than complete remitters (62.8 [12.6] versus 80.4 [10.5], respectively; P < .0001). After six months, only 47% PR versus 77% CR reached normal functioning, and SOFAS ratings for PR were below normal range (76.2 [12.3] PR versus 84.6 [9.4] CR; P < .0001). PR reported three times more days absent from work due to sickness than CR (63 days versus 20 days; P < .001).ConclusionWe conclude that PR of an MDD episode is associated with significant functional impairment that persists even after nine months of antidepressant treatment. Our results underline the importance of treating the patient until achieving full remission.
Collapse
|
7
|
Piedallu C, Chéret V, Denux JP, Perez V, Azcona JS, Seynave I, Gégout JC. Soil and climate differently impact NDVI patterns according to the season and the stand type. Sci Total Environ 2019; 651:2874-2885. [PMID: 30463140 DOI: 10.1016/j.scitotenv.2018.10.052] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/20/2018] [Revised: 10/04/2018] [Accepted: 10/04/2018] [Indexed: 06/09/2023]
Abstract
Several studies use satellite-based normalized difference vegetation index (NDVI) to monitor the impact of climate change on vegetation covers. Good understanding of the drivers of NDVI patterns is hindered by the difficulties in disentangling the effects of environmental factors from anthropogenic changes, by the limited number of environmental predictors studied, and by the diversity of responses according to periods and land covers. This study aims to improve our understanding of the different environmental drivers of NDVI spatial variations for different stand type characteristics of mountain and Mediterranean biomes. Using NDVI values extracted from MODIS Terra time series, we calculated Spring Greenness (SG) and annual Relative Greenness (RGRE) to depict spring and summer vegetation activity, respectively, in a contrasted area of 10,255 km2 located in the south of France. We modeled SG and RGRE at different scales, using 20 environmental predictors characterizing available energy, water supply, and nutrient supply calculated for different periods of the year. In spring, high minimum temperatures, good nitrogen availability, and acidic or neutral pH turned out to be determining for greenness, particularly for stand types located in altitude. In summer, an important soil water reserve and low temperatures promoted vegetation dynamics, particularly for stands located in areas with a Mediterranean climate. Our results show that NDVI dynamics was not only driven by climatic variability, and should not be studied using only mean temperature and rainfall. They highlight that different environmental factors act complementarily, and that soil parameters characterizing water stress and soil nutrition should be taken into account. While the factors limiting NDVI values varied according to the season and the position of the stands along the ecological gradients, we identified a global temperature and water-stress threshold when considering the whole vegetation.
Collapse
Affiliation(s)
- C Piedallu
- Université de Lorraine, AgroParisTech, Inra, Silva, F-54000 Nancy, AgroParisTech, 14 rue Girardet, F-54042 Nancy Cedex, France.
| | - V Chéret
- Dynafor, Université de Toulouse, INRA, INPT, INPT - EI PURPAN, Castanet-Tolosan, France, École d'Ingénieurs de PURPAN, 75 voie du TOEC, BP57611, 31076 Toulouse Cedex 3, France.
| | - J P Denux
- Dynafor, Université de Toulouse, INRA, INPT, INPT - EI PURPAN, Castanet-Tolosan, France, École d'Ingénieurs de PURPAN, 75 voie du TOEC, BP57611, 31076 Toulouse Cedex 3, France.
| | - V Perez
- Université de Lorraine, AgroParisTech, Inra, Silva, F-54000 Nancy, AgroParisTech, 14 rue Girardet, F-54042 Nancy Cedex, France.
| | - J S Azcona
- Université de Lorraine, AgroParisTech, Inra, Silva, F-54000 Nancy, AgroParisTech, 14 rue Girardet, F-54042 Nancy Cedex, France.
| | - I Seynave
- Université de Lorraine, AgroParisTech, Inra, Silva, F-54000 Nancy, AgroParisTech, 14 rue Girardet, F-54042 Nancy Cedex, France; Dynafor, Université de Toulouse, INRA, INPT, INPT - EI PURPAN, Castanet-Tolosan, France, École d'Ingénieurs de PURPAN, 75 voie du TOEC, BP57611, 31076 Toulouse Cedex 3, France.
| | - J C Gégout
- Université de Lorraine, AgroParisTech, Inra, Silva, F-54000 Nancy, AgroParisTech, 14 rue Girardet, F-54042 Nancy Cedex, France.
| |
Collapse
|
8
|
Flores-Díaz D, Arce Salinas C, Flores L, Lara F, Matus Santos J, Bargallo Rocha J, Perez V, Reynoso-Noveron N, Cabrera P, Mohar A. Impact of invasive lobular carcinoma in Latin American breast cancer patients’ disease-free survival: The new paradox. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy304.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Perez V, Shanmugasundaram R, Sifri M, Parr TM, Selvaraj RK. Effects of hydroxychloride and sulfate form of zinc and manganese supplementation on superoxide dismutase activity and immune responses post lipopolysaccharide challenge in poultry fed marginally lower doses of zinc and manganese. Poult Sci 2017; 96:4200-4207. [DOI: 10.3382/ps/pex244] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2017] [Accepted: 08/10/2017] [Indexed: 11/20/2022] Open
|
10
|
Sánchez EP, Miranda JG, Romero VC, Moreno J, Palma A, Pale LA, Leon J, Bulbena A, Perez V. Describing the assistance, the basis for improvement. Eur Psychiatry 2017. [DOI: 10.1016/j.eurpsy.2017.01.641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Abstract
IntroductionConsultation-liaison (CL) psychiatry is a branch of psychiatry that study and treat mental health of patients with other medical or surgical conditions. The assistance between hospitals and health services is heterogeneous.Aims and objectivesFor this reason, the objective of our research is to define the clinical characteristics from our CL service and check out the quality relationship with the applicant service, for improving future assistance.MethodsWe made a descriptive analysis of clinical variables from the patients who received assistance during 2 months by the CL service from the hospital del Mar, Barcelona. We got the frequencies and we used the Chi2 test for the comparison between variables: Diagnosis, appearance in the report and treatment in the report.ResultsTotal of the sample: 42 patients, 61.9% women. Mean age: 55.1 years. Psychiatric diagnosis was present before the assistance on 57.1% of the patients. The most frequent diagnosis was Adjustment Disorder (47.6%) and more than one diagnosis was made in the 14.3%. Near the half of the patients required only primary care assistance after the discharge from the hospital. In the 68.3% of the reports appeared information about CL assistance and the indicated treatment didn’t appear in all the reports. Statistically significant differences weren’t found in the comparisons.ConclusionsAdjustment Disorder is supposed to be the most common psychiatric diagnosis in our CL psychiatry service, as we found in the reviewed literature. The results reveal that relationships between services can be improved. More studies must be done for completing information in this issue.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
11
|
Madre M, Canales-Rodríguez EJ, Ortiz-Gil J, Murru A, Torrent C, Bramon E, Perez V, Orth M, Brambilla P, Vieta E, Amann BL. Neuropsychological and neuroimaging underpinnings of schizoaffective disorder: a systematic review. Acta Psychiatr Scand 2016; 134:16-30. [PMID: 27028168 DOI: 10.1111/acps.12564] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/08/2016] [Indexed: 12/11/2022]
Abstract
OBJECTIVES The neurobiological basis and nosological status of schizoaffective disorder remains elusive and controversial. This study provides a systematic review of neurocognitive and neuroimaging findings in the disorder. METHODS A comprehensive literature search was conducted via PubMed, ScienceDirect, Scopus and Web of Knowledge (from 1949 to 31st March 2015) using the keyword 'schizoaffective disorder' and any of the following terms: 'neuropsychology', 'cognition', 'structural neuroimaging', 'functional neuroimaging', 'multimodal', 'DTI' and 'VBM'. Only studies that explicitly examined a well defined sample, or subsample, of patients with schizoaffective disorder were included. RESULTS Twenty-two of 43 neuropsychological and 19 of 51 neuroimaging articles fulfilled inclusion criteria. We found a general trend towards schizophrenia and schizoaffective disorder being related to worse cognitive performance than bipolar disorder. Grey matter volume loss in schizoaffective disorder is also more comparable to schizophrenia than to bipolar disorder which seems consistent across further neuroimaging techniques. CONCLUSIONS Neurocognitive and neuroimaging abnormalities in schizoaffective disorder resemble more schizophrenia than bipolar disorder. This is suggestive for schizoaffective disorder being a subtype of schizophrenia or being part of the continuum spectrum model of psychosis, with schizoaffective disorder being more skewed towards schizophrenia than bipolar disorder.
Collapse
Affiliation(s)
- M Madre
- FIDMAG Research Foundation Germanes Hospitalàries, CIBERSAM, Barcelona, Spain
| | | | - J Ortiz-Gil
- FIDMAG Research Foundation Germanes Hospitalàries, CIBERSAM, Barcelona, Spain.,Hospital General de Granollers, Granollers, Catalonia, Spain
| | - A Murru
- Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Catalonia, Spain
| | - C Torrent
- Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Catalonia, Spain
| | - E Bramon
- Division of Psychiatry, University College London, London, UK
| | - V Perez
- Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain.,CIBERSAM, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - M Orth
- Department of Neurology, Ulm University, Ulm, Germany
| | - P Brambilla
- Department of Neurosciences and Mental Health, Psychiatric Clinic, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.,Department of Psychiatry and Behavioural Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA
| | - E Vieta
- Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Catalonia, Spain
| | - B L Amann
- FIDMAG Research Foundation Germanes Hospitalàries, CIBERSAM, Barcelona, Spain
| |
Collapse
|
12
|
Galindo L, Pastoriza F, Bergé D, Mané A, Roé N, Pujol N, Picado M, Bulbena A, Perez V, Vilarroya O. Abnormal connectivity in dorsolateral prefrontal cortex in schizophrenia patients and unaffected relatives. Eur Psychiatry 2016. [DOI: 10.1016/j.eurpsy.2016.01.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
ObjectivesThe aim of this study is to explore connectivity of the left dorsolateral prefrontal cortex (LDLPC) by functional magnetic resonance imaging during resting state, in subjects affected by schizophrenia and unaffected relatives.MethodsWe recruited a group of 29 patients diagnosed with schizophrenia, who were treated with atypical antipsychotics, who are and were clinically stable in the last 6 months and had an illness duration range from 5 up to 15 years. We also recruited a group of 23 unaffected relatives, without history of other mental, neurological or somatic disease and a group of 37 healthy volunteers. No subject in any of the three groups met criteria for substance use disorders.All three groups were clinically evaluated, and a functional magnetic resonance during Resting State was performed.Functional images were reoriented to the first scan, normalized to the MNI EPI template and smoothed with an 8 mm Gaussian kernel, with SPM. The CONN-FMRI Toolbox v1.2 was used to create individual subject seed-to-voxel connectivity maps, to the corresponding seeds of the default mode network.ResultsFig. 1.ConclusionsOur results show a significant increase in connectivity between LDLPC and anterior prefrontal cortex, dorsolateral prefrontal cortex and somatosensory association areas, especially between patients and controls. It is noteworthy to mention that we found a significant decrease in connectivity between LDLPC and supramarginal gyrus, superior temporal gyrus and somatosensory association areas between unaffected relatives and controls.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
13
|
Lago-Hernandez CA, Feldman H, O'Donnell E, Mahal BA, Perez V, Howard S, Rosenthal M, Cheng SC, Nguyen PL, Beard C, D'Amico AV, Sweeney CJ. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion. Ann Oncol 2015; 26:1396-401. [PMID: 25888612 DOI: 10.1093/annonc/mdv180] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2014] [Accepted: 04/07/2015] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Active surveillance is an increasingly accepted approach for managing patients with germ-cell tumors (GCTs) after an orchiectomy. Here we investigate a time-to-relapse stratification scheme for clinical stage 1 (CS1) nonseminoma GCT (NSGCT) patients according to factors associated with relapse and identify a group of patients with a lower frequency and longer time-to-relapse who may require an alternative surveillance strategy. PATIENTS AND METHODS We analyzed 266 CS1 GCT patients from the IRB-approved DFCI GCT database that exclusively underwent surveillance following orchiectomy from 1997 to 2013. We stratified NSGCT patients according to predominance of embryonal carcinoma (EmbP) and lymphovascular invasion (LVI), using a 0, 1, and 2 scoring system. Cox regression and conditional risk analysis were used to compare each NSGCT group to patients in the seminomatous germ-cell tumor (SGCT) category. Median time-to-relapse values were then calculated among those patients who underwent relapse. Relapse-free survival curves were generated using the Kaplan-Meier method. RESULTS Fifty (37%) NSGCT and 20 (15%) SGCT patients relapsed. The median time-to-relapse was 11.5 versus 6.3 months for the SGCT and NSGCT groups, respectively. For NSGCT patients, relapse rates were higher and median time-to-relapse faster with increasing number of risk factors (RFs). Relapse rates (%) and median time-to-relapse (months) were 25%/8.5 months, 41%/6.8 months and 78%/3.8 months for RF0, RF1 and RF2, respectively. We found a statistically significant difference between SGCT and patients with one or two RFs (P < 0.001) but not between SGCT and NSGCT RF0 (P = 0.108). CONCLUSION NSGCT patients grouped by a risk score system based on EmbP and LVI yielded three groups with distinct relapse patterns -and patients with neither EmbP nor LVI appear to behave similar to SGCT.
Collapse
Affiliation(s)
- C A Lago-Hernandez
- Harvard Medical School, Boston Department of Medical Oncology-Genitourinary Division, Dana-Farber Cancer Institute, Boston
| | - H Feldman
- Albert Einstein College of Medicine, New York Department of Medical Oncology-Genitourinary Division, Dana-Farber Cancer Institute, Boston
| | - E O'Donnell
- Department of Medical Oncology-Genitourinary Division, Dana-Farber Cancer Institute, Boston
| | - B A Mahal
- Harvard Medical School, Boston Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston
| | - V Perez
- University of Puerto Rico Medical School, San Juan PR
| | - S Howard
- Departments of Imaging, Dana-Farber Cancer Institute, Boston, USA
| | - M Rosenthal
- Departments of Imaging, Dana-Farber Cancer Institute, Boston, USA
| | - S C Cheng
- Biostatistics/Computational Biology, Dana-Farber Cancer Institute, Boston, USA
| | - P L Nguyen
- Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston
| | - C Beard
- Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston
| | - A V D'Amico
- Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston
| | - C J Sweeney
- Department of Medical Oncology-Genitourinary Division, Dana-Farber Cancer Institute, Boston
| |
Collapse
|
14
|
Haller M, Van Biesen W, Webster AC, Vanholder R, Nagler EV, Lee JE, Kim SK, Park SK, Yun GY, Choi HY, Ha SK, Park HC, Hernandez-Sevillano B, Rodriguez JR, Perez del Valle K, de Lorenzo A, Salas P, Bienvenido M, Sanchez-Heras M, Basterrechea MA, Tallon S, de Arriba G, Greenberg A, Verbalis J, Burst V, Haymann JP, Poch E, Chiodo J, Nagler EV, Vanmassenhove J, van der Veer SN, Nistor I, Van Biesen W, Webster AC, Vanholder R, Pignataro A, Alfieri V, Cesano G, Timbaldi M, Torta E, Boero R, Nagler EV, Haller MC, Van Biesen W, Vanholder R, Webster AC, Cucchiari D, Podesta M, Merizzoli E, Angelini C, Badalamenti S, Alves MT, Moyses RM, Jorgetti V, Heilberg I, Menon V, Lhotta K, Muendlein A, Meusburger E, Zitt E, Bijarnia R, Pasch A, Hwang SW, Lee CH, Kim GH, Leckstrom D, Pereira C, Bultitude M, McGrath A, Goldsmith DJ, Vasquez D, Fernandez B, Palomo S, Aller C, Gordillo R, Perez V, Bustamante J, Coca A, Vitale C, Bagnis C, Tricerri A, Gallo L, Dutto F, Migliardi M, Marangella M, Outerelo C, Figueiredo P, Freitas J, Teixeira Costa F, Ramos A, Rambod M, Melikterminas E, Atallah H, Saadi M, Connery S, Mulla Z, Tolouian R, Cristofaro R, Masola V, Ceol M, Priante G, Familiari A, Gambaro G, Anglani F. Acid-base / electrolytes / nephrolithiasis. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft139] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
15
|
Borras M, Roig J, Betriu A, Vilar A, Hernandez M, Martin M, Fernandez ED, Dounousi E, Kiatou V, Papagianni A, Zikou X, Pappas K, Pappas E, Tatsioni A, Tsakiris D, Siamopoulos KC, Kim JK, Kim Y, Kim SG, Kim HJ, Ahn SY, Chin HJ, Oh KH, Ahn C, Chae DW, Yazici R, Altintepe L, Bakdik S, Guney I, Arslan S, Topal M, Karagoz A, Stefan G, Mircescu G, Capusa C, Stancu S, Petrescu L, Alecu S, Nedelcu D, Bennett AHL, Pham H, Garrity M, Magdeleyns E, Vermeer C, Zhang M, Ni Z, Zhu M, Yan J, Mou S, Wang Q, Qian J, Saade A, Karavetian M, ElZein H, de Vries N, de Haseth DE, Lay Penne E, van Dam B, Bax WA, Bots ML, Grooteman MPC, van den Dorpel RA, Blankenstijn PJ, Nube MJ, Wee PM, Park JH, Jo YI, Lee JH, Cianfrone P, Comi N, Lucisano G, Piraina V, Talarico R, Fuiano G, Toyonaga M, Fukami K, Yamagishi SI, Kaida Y, Nakayama Y, Ando R, Obara N, Ueda S, Okuda S, Granatova J, Havrda M, Hruskova Z, Tesar V, Viklicky O, Rysava R, Rychlik I, Kratka K, Honsova E, Vernerova Z, Maluskova J, Vranova J, Bolkova M, Borecka K, Benakova H, Zima T, Lu KC, Yang HY, Su SL, Cao YH, Lv LL, Liu BC, Zeng R, Gao XF, Deng YY, Boelaert J, t' Kindt R, Glorieux G, Schepers E, Jorge L, Neirynck N, Lynen F, Sandra P, Sandra K, Vanholder R, Yamamoto T, Nameta M, Yoshida Y, Uhlen M, Shi Y, Tang J, Zhang J, An Y, Liao Y, Li Y, Tao Y, Wang L, Koibuchi K, Tanaka K, Aoki T, Miyagi M, Sakai K, Aikawa A, Martins AR, Branco PQ, Serra FM, Matias PJ, Lucas CP, Adragao T, Duarte J, Oliveira MM, Saraiva AM, Barata JD, Masola V, Zaza G, Granata S, Proglio M, Pontrelli P, Abaterusso C, Schena F, Gesualdo L, Gambaro G, Lupo A, Pruijm M, Hofmann L, Stuber M, Zweiacker C, Piskunowicz M, Muller ME, Vogt B, Burnier M, Togashi N, Yamashita T, Mita T, Ohnuma Y, Hasegawa T, Endo T, Tsuchida A, Ando T, Yoshida H, Miura T, Bevins A, Assi L, Ritchie J, Jesky M, Stringer S, Kalra P, Hutchison C, Harding S, Cockwell P, Viccica G, Cupisti A, Chiavistelli S, Borsari S, Pardi E, Centoni R, Fumagalli G, Cetani F, Marcocci C, Scully P, O'Flaherty D, Sankaralingam A, Hampson G, Goldsmith DJ, Pallet N, Chauvet S, Beaune P, Nochy D, Thervet E, Karras A, Bertho G, Gallyamov MG, Saginova EA, Severova MM, Krasnova TN, Kopylova AA, Cho E, Jo SK, Kim MG, Cho WY, kim HK, Trivin C, Metzger M, Boffa JJ, Vrtovsnik F, Houiller P, Haymann JP, Flamant M, Stengel B, Thervet E, Roozbeh J, Yavari V, Pakfetrat M, Zolghadr AA, Kim CS, Kim MJ, Kang YU, Choi JS, Bae EH, Ma SK, Kim SW, Lemoine S, Guebre-Egziabher F, Dubourg L, Hadj-Aissa A, Blumberg S, Katzir Z, Biro A, Cernes R, Barnea Z, Vasquez D, Gordillo R, Aller C, Fernandez B, Jabary N, Perez V, Mendiluce A, Bustamante J, Coca A, Goek ON, Sekula P, Prehn C, Meisinger C, Gieger C, Suhre K, Adamski J, Kastenmuller G, Kottgen A, Kuzniewski M, Fedak D, Dumnicka P, Solnica B, Kusnierz-Cabala B, Kapusta M, Sulowicz W, Drozdz R, Zawada AM, Rogacev KS, Hummel B, Fliser D, Geisel J, Heine GH, Kretschmer A, Volsek M, Krahn T, Kolkhof P, Kribben A, Bruck H, Koh ES, Chung S, Yoon HE, Park CW, Chang YS, Shin SJ, Deagostini MC, Vigotti FN, Ferraresi M, Consiglio V, Scognamiglio S, Moro I, Clari R, Daidola G, Versino E, Piccoli GB, Mammadrahim Agayev M, Mehrali Mammadova I, Qarib Ismayilova S, Anguiano L, Riera M, Pascual J, Barrios C, Betriu A, Valdivielso JM, Fernandez E, Soler MJ, Tsarpali V, Liakopoulos V, Panagopoulou E, Kapoukranidou D, Spaia S, Kostopoulou M, Michalaki A, Nikitidou O, Dombros N, Zhu F, Abba S, Flores-Gama C, Williams C, Cartagena C, Carter M, Kotanko P, Levin NW, Kolesnyk M, Stepanova N, Driyanska V, Stashevska N, Kundin V, Shifris I, Dudar I, Zaporozhets O, Keda T, Ishchenko M, Khil M, Choe JY, Nam SA, Kim J, Cha JH, Gliga ML, Irimescu CG, Caldararu CD, Gliga MG, Toma LV, Gomotarceanu A, Park Y, Kim Y, Jeon J, Kwon SK, Kim SJ, Kim SM, Kim HY, Montero N, Soler MJ, Barrios C, Marquez E, Berrada A, Arias C, Prada JA, Orfila MA, Mojal S, Vilaplana C, Pascual J, Vigotti FN, Attini R, Parisi S, Fassio F, Deagostini MC, Ghiotto S, Ferraresi M, Clari R, Biolcati M, Todros T, Piccoli GB, Jin K, Vaziri ND, Tramonti G, Romiti N, Chieli E, Maksudova AN, Khusnutdinova LA, Tang J, Shi Y, Zhang J, Li Y, An Y, Tao Y, Wang L, Reque JE, Quiroga B, Lopez JM, Verdallez UG, Garcia de Vinuesa M, Goicoechea M, Nayara PG, Arroyo DR, Luno J, Tanaka H, Flores-Gama C, Abbas SR, Williams C, Cartagena C, Carter M, Thijssen S, Kotanko P, Levin NW, Zhu F, Berthoux FC, Azzouz L, Afiani A, Ziane A, Mariat C, Fournier H, Kusztal M, Dzierzek P, Witkowski G, Nurzynski M, Golebiowski T, Weyde W, Klinger M, Altiparmak MR, Seyahi N, Trabulus S, Bolayirli M, Andican ZG, Suleymanlar G, Serdengecti K, Niculae A, Checherita IA, Neagoe DN, Ciocalteu A, Seiler S, Rogacev KS, Pickering JW, Emrich I, Fliser D, Heine G, Bargnoux AS, Obiols J, Kuster N, Fessler P, Badiou S, Dupuy AM, Ribstein J, Cristol JP, Yanagisawa N, Ando M, Ajisawa A, Tsuchiya K, Nitta K, Bouquegneau A, Cavalier E, Krzesinski JM, Delanaye P, Tominaga N, Shibagaki Y, Kida K, Miyake F, Kimura K, Ayvazyan A, Rameev V, Kozlovskaya L, Simonyan A, Scholze A, Marckmann P, Tepel M, Rasmussen LM, Hara M, Ando M, Tsuchiya K, Nitta K, Kanai H, Harada K, Tamura Y, Kawai Y, Al-Jebouri MM, Madash SA, Leonidovna Berezinets O, Nicolaevich Rossolovskiy A. Lab methods / biomarkers. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft108] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
16
|
Huhmann MB, Perez V, Alexander DD, Thomas DR. A self-completed nutrition screening tool for community-dwelling older adults with high reliability: a comparison study. J Nutr Health Aging 2013; 17:339-44. [PMID: 23538656 DOI: 10.1007/s12603-013-0015-x] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
OBJECTIVES Malnutrition is common in community-dwelling older adults and is associated with poor outcomes including hospitalization and mortality. Recently, a 6-question short form mini nutritional assessment (SF-MNA) was validated for rapid nutrition screening. Ideally, nutrition screening could be performed by individuals or their caregivers prior to or during an outpatient clinical visit, thus allowing for the ongoing monitoring of nutritional status among older adults. DESIGN We compared the SF-MNA administered by a healthcare professional (HCP) to a 6-item self-administered screening tool (Self-MNA) in 463 community dwelling older adults who gave informed consent. The population was 60% women with a mean age of 76.8±6.8 years. The HCP was blinded to the results of the Self-MNA questionnaire. RESULTS Using the SF-MNA, 27% of subjects were malnourished, 38% were at risk, and 35% had normal nutrition status. The agreement between the Self-MNA and the SF-MNA was 99% (Self-MNA sensitivity 99%, specificity 98%, false negative rate 1%, false positive rate 2%) for identifying Malnourished subjects and 83% (sensitivity 89%, specificity 77%, false negative rate 11%, false positive rate 23%) for identifying At Risk of Malnutrition compared to the MNA-SF administered by a HCP. CONCLUSION We found that the Self-MNA demonstrates sufficient inter-rater reliability for use in nutrition screening among community-dwelling older adults. Further validation studies and the possible impact of language translation should be pursued.
Collapse
|
17
|
Bass B, Perez V, Yang H, Tsai T, Holzgraefe D, Chewning J, Maxwell C. Impact of Pichia guilliermondii on sow, litter, and weaned pig immune performance. J Anim Sci 2013; 90 Suppl 4:445-7. [PMID: 23365405 DOI: 10.2527/jas.53982] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Three groups of gestating gilts and sows (Exp. 1; n = 98) were used to determine the effects of Pichia guilliermondii (Pg), a whole yeast product (CitriStim, ADM Alliance Nutrition), on dam and litter immune parameters. At breeding, gilts and sows were allotted to 1 of 3 treatments maintained through lactation: sow control (SC) diet or SC supplemented with 0.1 (S1) or 0.2% (S2) Pg. Pigs from groups 1 (Exp. 2) and 2 (Exp. 3) were weaned (21 d) and allotted in a 3 (SC, S1, or S2) × 2 [nursery with Pg (NPg) or without Pg (NC)] factorial arrangement in a randomized complete block design. In Exp. 2 blood samples were collected on days 5 and 28 postweaning for analysis. In Exp. 3, 36 pigs were individually penned and challenged with lipopolysaccharide (25 μg/kg BW intramuscular; 0 h). Individual BW, ADFI, and rectal temperature (RT) were collected at -48, -24, 0, 24, and 48 h and blood samples were collected at 0, 5, and 24 h for analysis. In Exp. 1, total neutrophil count (NEU) and neutrophil:lymphocyte ratio (NLR) were greater on day 110 of gestation (P < 0.05) in S1 than SC. At weaning there was a liner increase (P < 0.05) in NEU, NLR, and percentage of total leukocytes (PTL) that were NEU as level of Pg increased in sow diets. In Exp. 2, pigs from S1 had increased (P < 0.05) overall IgG than SC. The PTL that were eosinophils was greater in pigs from S2 fed NPg on day 5 than NC (P < 0.05) and increased in all pigs from S2 on day 28 (sow linear, P < 0.1). On day 28, total leukocytes and eosinophils were increased in pigs from SC [quadratic response (Q), P < 0.05]. In Exp. 3, a linear increase (P < 0.05) in ADFI was observed at -24 to 0 h, -48 to 0 h, and 24 to 48 h as the level of Pg increased in sow diets. There was a linear increase in RT at -48, -24, 0, and 5 h with increasing Pg inclusion in sow diets (P < 0.05). However, RT decreased more from 5 to 24 h in pigs from sows receiving Pg. The number of monocytes and PTL that were monocytes were higher in S2 compared to SC and S1 (P < 0.05). Also, NEU were reduced at 5 h in S1 (P < 0.05), NLR was lower in S2 at 0 h and S1 at 5 h, IL-1β concentration was greater in SC at 0 h and S1 at 5 h, and IL-6 concentration was greater in S2 at 0 h and S1 at 5 h (P < 0.05). Furthermore, blood urea N (BUN) was higher in NC at 0 and 5 h than NPg (P < 0.05). In conclusion, Pg appears to impact immune response criteria of sows and weaned pigs.
Collapse
Affiliation(s)
- B Bass
- University of Arkansas, Fayetteville, AR, USA
| | | | | | | | | | | | | |
Collapse
|
18
|
Thomas D, Perez V, Kaspar K, Huhmann M. Validity of a new, patient-completed nutrition-screening tool as compared to the mini-nutritional assessment (MNA®)-short form (MNA®-SF). Eur Geriatr Med 2012. [DOI: 10.1016/j.eurger.2012.07.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
19
|
Perez V, Alexander D, Bailey W. Air Ions and Mood Outcomes: a Review and Metaanalysis. Ann Epidemiol 2012. [DOI: 10.1016/j.annepidem.2012.06.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Meneses J, Gámez P, Mariscal A, Marrón C, Díaz-Hellín V, Cortes M, de Pablo A, Lopez E, Perez V, Gonzalez O, Juarros L, Martinez I, Hermoso F, Ávila R, Zuluaga M, de Nicolás J. Development of a Non–Heart-Beating Donor Program and Results After the First Year. Transplant Proc 2012; 44:2047-9. [DOI: 10.1016/j.transproceed.2012.07.092] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Romera I, Perez V, Menchón J, Delgado-Cohen H, Polavieja P, Gilaberte I. Corrigendum to “Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A 6-month prospective epidemiological study”. [Eur Psychiatry 2010;25:58–65]. Eur Psychiatry 2012. [DOI: 10.1016/j.eurpsy.2011.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
|
22
|
Serino G, Sallustio F, Cox SN, Pesce F, Schena FP, Papista C, Papista C, Berthelot L, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PHM, Tamouza H, Jamin A, Bex-Coudrat J, Gestin A, Boumediene A, Arcos-Fajardo M, England P, Pillebout E, Walker F, Daugas E, Vrtosvnik F, Benhamou M, Cogne M, Moura IC, Monteiro RC, Sarcina C, Sarcina C, Tinelli C, Ferrario F, Visciano B, Terraneo V, Pani A, Fogazzi GB, Furiani S, Alberghini E, Buzzi L, Pozzi C, Graterol F, Navarro-Munoz M, Lopez D, Ibernon M, Navarro M, Troya M, Perez V, Sala N, Serra A, Bonet J, Romero R, Tatematsu M, Yasuda Y, Sato W, Tsuboi N, Maruyama S, Imai E, Matsuo S. IgA Nephropathy and urinary proteomics. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
23
|
Font LM, Fontana A, Galceran MT, Iturrino L, Perez V. Orthogonal analytical screening for liquid chromatography–mass spectrometry method development and preparative scale-up. J Chromatogr A 2011; 1218:74-82. [DOI: 10.1016/j.chroma.2010.10.102] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2010] [Revised: 10/01/2010] [Accepted: 10/26/2010] [Indexed: 11/25/2022]
Affiliation(s)
- Luis M Font
- Enabling Analytical Technologies, Janssen Research & Development a Division of Janssen-Cilag S.A., c/Jarama 75, 45007 Toledo, Spain.
| | | | | | | | | |
Collapse
|
24
|
Perez V, Delgado L, Benavides J, Ferreras M, García-Marín J, Gutiérrez J. Epitheliogenesis Imperfecta in Churra Lambs. J Comp Pathol 2010. [DOI: 10.1016/j.jcpa.2010.09.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
25
|
Perez V, Awh E, Vogel EK. Object complexity does not reduce the number of representations that can be maintained in visual working memory. J Vis 2010. [DOI: 10.1167/7.9.852] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
26
|
Perez V, Vogel E. Relating visual working memory capacity and visual attention in schizophrenia-spectrum individuals. J Vis 2010. [DOI: 10.1167/8.6.1172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
27
|
Vogel EK, Ikkai A, Perez V. Do perceptually challenging objects consume more working memory capacity? J Vis 2010. [DOI: 10.1167/6.6.34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
28
|
Perez V, Galea S, Kalbfleisch J, Monto A, Aiello A. The effect of influenza-like illness symptoms and laboratory confirmed influenza A on hand hygiene and other health habits among US University students. Int J Infect Dis 2010. [DOI: 10.1016/j.ijid.2010.02.1706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
29
|
Arranz B, San L, Ramírez N, Dueñas RM, Perez V, Salavert J, Corripio I, Alvarez E. Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis. Acta Psychiatr Scand 2009; 119:71-7. [PMID: 18764839 DOI: 10.1111/j.1600-0447.2008.01253.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE The study aimed to establish clinical predictors of non-affective acute remitting psychosis (NARP) and assess whether these patients showed a distinct serotonergic profile. METHOD First-episode never treated psychotic patients diagnosed of paranoid schizophrenia (n=35; 21 men and 14 women) or NARP (n=28; 15 men and 13 women) were included. RESULTS NARP patients showed significantly lower negative symptomatology, better premorbid adjustment, shorter duration of untreated psychosis, more depressive symptomatology and a lower number of 5-HT2A receptors than the paranoid schizophrenia patients. In the logistic regression, the four variables associated with the presence of NARP were: low number of 5-HT2A receptors; good premorbid adjustment; low score in the item 'hallucinatory behaviour' and reduced duration of untreated psychosis. CONCLUSION Our findings support the view that NARP is a highly distinctive condition different from either affective psychosis or other non-affective psychosis such as schizophrenia, and highlight the need for its validation.
Collapse
Affiliation(s)
- B Arranz
- Sant Joan de Deu, Serveis de Salut Mental, Sant Boi de Llobregat, Barcelona, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Perez V, Aiello A, Murray G, Coulborn R, Monto A. Fear, Stress, and Reported Pandemic Influenza Response among University Students in the US. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.1292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
31
|
Cabeza M, Heuze I, Sánchez M, Bratoeff E, Ramírez E, Rojas A, Orozco A, Mungía A, Agustín G, Cuatepotzo L, Gonzalez C, Palma S, Padilla D, Perez V, Jimenez G. Relative binding affinity of novel steroids to androgen receptors in hamster prostate. J Enzyme Inhib Med Chem 2008; 20:357-64. [PMID: 16206830 DOI: 10.1080/14756360500148924] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Abstract
The in vivo and in vitro antiandrogenic activity of four aromatic esters 10a-10d, one aliphatic ester 10e based on the pregna-4,16-diene-6, 20-dione structure and two aromatic 17c, 17d and two aliphatic valeroyloxy esters 17a, 17b based on the more saturated 4-pregnene-6,20-dione skeleton was examined. The biological activity of steroids 9, 10a-10e and 17a-17d, was determined using prostate glands from gonadectomized adult male golden hamsters. In the in vitro studies, the relative binding affinity of these steroids to cytoplasmic androgen receptor (AR) of hamster prostate was determined from, the corresponding IC50 values obtained from the competitive binding plots. The standards dihydrotestosterone (DHT) and cyproterone (CA) acetate used have displaced [3H]DHT from the AR with an IC50 value of 3.2 and 4.4 nM respectively. All steroidal compounds synthesized in this study showed a binding affinity for the androgen receptor, present in the cytosol from prostate hamster; compounds 10a-10c showed the highest affinities for this receptor. The in vivo experiments showed that all steroidal derivatives were subcutaneously active, since they decreased the weight of the prostate gland in gonadectomized hamsters treated with DHT, and are antagonists for the androgen receptor since they block the DHT-induced prostate weight gain. The derivatives having the more conjugated 4,16-pregnadiene-6, 20-dione system (10a-10c) exhibited a higher antiandrogenic activity than the corresponding steroids (17a-17d) based on the more saturated 4-pregnene-6,20-dione system.
Collapse
Affiliation(s)
- M Cabeza
- Department of Biological Systems and Animal Production, Metropolitan University-Xochimilco, Mexico DF, Mexico.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Ramirez S, Salmeron J, Del Amo A, Perez V, Thomas A, Navarro C. P.440 Megacoronoid: a cause of temporomandibular joint dysfunction. J Craniomaxillofac Surg 2008. [DOI: 10.1016/s1010-5182(08)72228-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
33
|
Pascual JC, Soler J, Baiget M, Cortés A, Menoyo A, Barrachina J, Ropero M, Gomà M, Alvarez E, Perez V. Association between the serotonin transporter gene and personality traits in borderline personality disorder patients evaluated with Zuckerman-Zuhlman Personality Questionnaire (ZKPQ). Actas Esp Psiquiatr 2007; 35:382-386. [PMID: 18004675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
INTRODUCTION The serotoninergic system seems to be implicated in characteristic symptoms of borderline personality disorder (BPD) such as affective instability, impulsivity or suicide. Some studies suggest an association between serotonin transporter gene (5-HTT) polymorphisms and some BPD symptoms. Short allele (S) of the 5-HTTLPR polymorphism in the promoter region has been shown to be associated with impulsivity, aggressive behavior, anxiety and neuroticism. Of the variable number of tandem repeat (VNTR) polymorphism in intron 2, BPD patients showed higher frequencies of the allele with the 10 repeats. The aim of this study was to determine the association between 5- HTTLPR and VNTR polymorphism of 5-HTT and personality traits in borderline personality disorder. METHOD A total of 65 BPD patients diagnosed by means of semi-structured interviews SCID-II and DIB-R were included. Two common polymorphisms of 5-HTT were genotyped: the 5-HTTLPR in the promoter region and VNTR in intron 2. Personality traits were assessed by the Zuckerman-Kuhlman Personality Questionnaire (ZKPQ). RESULTS Patients with L allele (L/S or L/L) in the 5-HTTLPR polymorphism showed lower scores on the subscale of liking parties and friends. Patients with the allele with 10 repeat of the VNTR polymorphism, showed lower scores in impulsivity, sensation seeking and in the subscale liking of parties and friends. CONCLUSIONS The results suggest a significant association between the 5-HTT gene and some personality traits in BPD. This gene may play a role in the etiology of borderline personality disorder.
Collapse
Affiliation(s)
- J C Pascual
- Psychiatry Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona , Barcelona, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Stricker R, Echenard M, Eberhart R, Chevailler MC, Perez V, Quinn FA, Stricker R. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 2007; 157:509-14. [PMID: 17893266 DOI: 10.1530/eje-07-0249] [Citation(s) in RCA: 178] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND Maternal thyroid dysfunction has been associated with a variety of adverse pregnancy outcomes. Laboratory measurement of thyroid function plays an important role in the assessment of maternal thyroid health. However, occult thyroid disease and physiologic changes associated with pregnancy can complicate interpretation of maternal thyroid function tests (TFTs). OBJECTIVE AND METHODS To 1) establish the prevalence of laboratory evidence for autoimmune thyroid disease (AITD) in pregnant women; 2) establish gestational age-specific reference intervals for TFTs in women without AITD; and 3) examine the influence of reference intervals on the interpretation of TFT in pregnant women. Serum samples were collected from 2272 pregnant women, and TFT performed. Gestational age-specific reference intervals were determined in women without AITD, and then compared with the non-pregnant assay-specific reference intervals for interpretation of testing results. RESULTS Thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (Tg-Ab) were positive in 10.4 and 15.7% of women respectively. TPO-Ab level was related to maternal age, but TPO-Ab status, Tg-Ab status, and Tg-Ab level were not. Women with TSH > 3.0 mIU/l were significantly more likely to be TPO-Ab positive. Gestational age-specific reference intervals for TFT were significantly different from non-pregnant normal reference intervals. Interpretation of TFT in pregnant women using non-pregnant reference intervals could potentially result in misclassification of a significant percentage of results (range: 5.6-18.3%). CONCLUSION Laboratory evidence for thyroid dysfunction was common in this population of pregnant women. Accurate classification of TFT in pregnant women requires the use of gestational age-specific reference intervals.
Collapse
Affiliation(s)
- Rt Stricker
- DIANALAB SA, 6 rue de la Colline, Genève, 1205 Switzerland.
| | | | | | | | | | | | | |
Collapse
|
35
|
Perez V, Barrachina J, Soler J, Pascual JC, Campins MJ, Puigdemont D, Alvarez E. The clinical global impression scale for borderline personality disorder patients (CGI-BPD): a scale sensible to detect changes. Actas Esp Psiquiatr 2007; 35:229-35. [PMID: 17592784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
The CGI-BPD scale is an adaptation of the Clinical Global Impression (CGI) scale designed to assess severity and post-intervention changes in patients with Borderline Personality Disorder (BPD). It contains 10 items that score the nine relevant psychopathological domains of BPD, plus an additional global score. The CGI-BPD has two formats, the CGI-BPD-S, to evaluate the present severity, and the CGIBPD- I to evaluate improvement. To establish the psychometric properties of the CGI-BPD, the test was administered to 78 BPD patients, 11 men and 67 women, within the framework of a 4-month therapeutic intervention. The modified scale showed good validity and reliability (alpha 0.85 and 0.89; CCI: 0.86 and 0.78), adequate sensitivity to change, and a two-factor structure accounting for 67.4 % of total variance. While remaining simple to administer, the CGI-BPD may correct the excessive generalisation contained in its original version and is a useful tool to evaluate severity and change in BPD patients.
Collapse
Affiliation(s)
- V Perez
- Departmento de Psiquiatría, Hospital de la Santa Creu i Sant Pau, Universidad Autónoma (UAB) Barcelona, Spain.
| | | | | | | | | | | | | |
Collapse
|
36
|
|
37
|
Pascual JC, Madre M, Puigdemont D, Oller S, Corripio I, Díaz A, Faus G, Perez V, Alvarez E. [A naturalistic study: 100 consecutive episodes of acute agitation in a psychiatric emergency department]. Actas Esp Psiquiatr 2006; 34:239-44. [PMID: 16823684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
INTRODUCTION Psychomotor agitation is a common event in psychiatric emergency services (PES) with a prevalence of approximately 10 %. There is no general consensus on to how to manage psychomotor agitation; benzodiazepines, typical antipsychotics and now atypical antipsychotics have demonstrated similar efficacy. The aim of our study was to describe the epidemiology and clinical management of agitation in "real-life" in a psychiatric emergency service. METHODS A naturalistic study was performed in acutely agitated patients recruited consecutively in a psychiatric emergency service. Demographics, clinical and therapeutic characteristics were analyzed. Efficacy was assessed by the Excitement Component of the Positive and Negative Syndrome Scale (PANSS-EC) and the Agitation-Calmness Evaluation Scale (ACES). Pragmatic variables such as the need for second pharmacological intervention and the need for physical restraints were assessed. RESULTS The study included 100 patients with psychomotor agitation. Mean age was 36.2 % and 54% were women. The most prevalent diagnoses were psychotic disorder (48 %) and personality disorder (24 %). Physical restraint was required in 39 % of patients and 52 % accepted oral treatment. Haloperidol was the most frequent oral treatment and olanzapine was the most frequent intramuscular treatment. CONCLUSIONS A naturalistic approach provides data based on clinical reality in psychiatric emergency services. Strict research designs of clinical trials of efficacy imply sample selection biases and are generally distanced from the clinical reality. Atypical antipsychotics have become the first-line treatment in acute agitation
Collapse
Affiliation(s)
- J C Pascual
- Servicio de Psiquiatría, Hospital de la Santa Creu i Sant Pau, Barcelona
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Badiou S, Perez V, Dupuy AM, Deswarte G, Frapier JM, Albat B, Cristol JP. High Prevalence of Small Dense LDL as an Underestimated Component of Heart Transplantation–Induced Dyslipidemia: Potential Role in Graft Coronary Vasculopathy? Transplant Proc 2005; 37:2877-8. [PMID: 16182840 DOI: 10.1016/j.transproceed.2005.05.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Heart transplantation-induced dyslipidemia is a recognized risk factor for cardiac allograft vasculopathy that affects survival prognosis. Beyond increased lipids, low-density lipoprotein (LDL) size and systemic factors, including glucose intolerance, oxidative stress, and inflammation, must be taken into account as components of the atherosclerotic risk. The aim of this study was to explore the atherogenic profile of heart transplant recipients (HTR) by assessing lipid parameters, glycemia, oxidative stress status, and inflammation in 59 transplant patients (follow-up of 6 +/- 3 years) compared to 20 healthy volunteers. Classical hypercholesterolemia and hypertriglyceridemia were observed in HTR compared to controls, associated with increased apoCIII levels (0.13 +/- 0.6 vs 0.07 +/- 0.03 g/L, P < .01). Mean LDL size was reduced in HTR compared to controls (25.22 +/- 0.72 vs 26.06 +/- 0.54 nm, P < .001) with an abnormally high prevalence (69% vs 0%, P < .001) of small dense LDL (<25.5 nm). Hyperglycemia (7.3 +/- 3 vs 5.4 +/- 0.8 mmol/L, P < .05) and inflammation (high-sensitive CRP: 3.1 +/- 3 vs 1.6 +/- 0.9 mg/L, P < .001) were evidenced in HTR since no difference in oxidative stress parameters was observed. In conclusion, a high prevalence of small dense LDL is an important component of posttransplantation dyslipidemia.
Collapse
Affiliation(s)
- S Badiou
- Laboratoire de Biochimie, Montpellier, France
| | | | | | | | | | | | | |
Collapse
|
39
|
Mayordomo JI, Madroñal C, Garcia-Lopez MJ, Burillo MA, Perez V, Janariz J, Murillo L, Andres R, Lara R, Lambea J, Alvarez Javier Sanz I. Safety analysis of docetaxel (T) and doxorubicin (A) followed by sequential capecitabine (X) as adjuvant chemotherapy of patients with node-positive operable breast cancer (BC). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- J. I. Mayordomo
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - C. Madroñal
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - M. J. Garcia-Lopez
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - M. A. Burillo
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - V. Perez
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - J. Janariz
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - L. Murillo
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - R. Andres
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - R. Lara
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - J. Lambea
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| | - I. Alvarez Javier Sanz
- Hosp Clinico Univ, Zaragoza, Spain; Inst de Oncologia Corachan, Barcelona, Spain; Hosp Nuestra Señora de Alarcos, Ciudad Real, Spain; Hosp Gen San Jorge, Huesca, Spain; Hosp de la Arritxaca, Murcia, Spain; Hosp de la Cruz Roja, Hospitalet (Barcelona), Spain; Hosp de Tudela, Tudela (Navarra), Spain
| |
Collapse
|
40
|
Kabanov AV, Komarov VM, Perez V. [The mechanism of accumulation of the large electric dipole moment of DNA molecule. PM3 quantum-chemical analysis]. Biofizika 2005; 50:434-43. [PMID: 15977832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
On the basis of the idea of the intrinsic polymorphism of Watson-Crick base pairing in DNA structure, the process of accumulation of the large electric dipole moment in model spiral stacks of canonical non-planar AT and GC pairs was analyzed using the quantum-chemistry methods. The dependence of the value and orientation of electrical dipole moment of a double helix on spiral length, geometry of base H-pairing, and the bending of the major axis of the helix were considered.
Collapse
|
41
|
Svihus B, Kløvstad K, Perez V, Zimonja O, Sahlström S, Schüller R, Jeksrud W, Prestløkken E. Physical and nutritional effects of pelleting of broiler chicken diets made from wheat ground to different coarsenesses by the use of roller mill and hammer mill. Anim Feed Sci Technol 2004. [DOI: 10.1016/j.anifeedsci.2004.08.009] [Citation(s) in RCA: 149] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
42
|
Borrega P, Lorenzo A, Madroñal C, Sanz JJ, Ruiz M, Centelles M, Casas A, González de La Puente C, Perez V, González-Barón M. Dose-dense neoadjuvant treatment with biweekly docetaxel (T) plus epirubicin (E) for locally advanced breast cancer (LABC). An ONCOPAZ Cooperative Group Study. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- P. Borrega
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - A. Lorenzo
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - C. Madroñal
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - J. J. Sanz
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - M. Ruiz
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - M. Centelles
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - A. Casas
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - C. González de La Puente
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - V. Perez
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| | - M. González-Barón
- Hospital San Pedro de Alcántara, Cáceres, Spain; Hospital de Puerto Real, Cádiz, Spain; Instituto de Oncología Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital Punta Europa, Algeciras, Spain; Hospital Sagrat Cor, Barcelona, Spain; Hospital Virgen del Rocío, Sevilla, Spain; Hospital Nuestra Señora de Valme, Sevilla, Spain; Hospital Univ Virgen de la Arritxaca, Murcia, Spain; Hospital La Paz, Madrid, Spain
| |
Collapse
|
43
|
Lara R, Mayordomo JI, Modolell A, Burillo M, Sanz J, Murillo L, Janariz J, Perez V, Andres R, Tres A. Feasibility of adjuvant chemotherapy with doxorubicin plus docetaxel followed by sequential capecitabine in patients with node positive breast cancer. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- R. Lara
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - J. I. Mayordomo
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - A. Modolell
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - M. Burillo
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - J. Sanz
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - L. Murillo
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - J. Janariz
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - V. Perez
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - R. Andres
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| | - A. Tres
- Hospital Clinico Universitario, Zaragoza, Spain; Instituto de Oncologia Corachan, Barcelona, Spain; Hospital San Jorge, Huesca, Spain; Hospital de Tudela, Tudela, Spain; Hospital de la Cruz Roja, Hospitalet (Barcelona), Spain; Hospital de la Arritxaca, Murcia, Spain
| |
Collapse
|
44
|
Balseiro A, Prieto JM, Espí A, Perez V, García Marín JF. Presence of focal and multifocal paratuberculosis lesions in mesenteric lymph nodes and the ileocaecal valve of cattle positive to the tuberculin skin test. Vet J 2003; 166:210-2. [PMID: 12902189 DOI: 10.1016/s1090-0233(02)00312-x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- A Balseiro
- Servicio Regional de Investigatión y Desarrollo Agroalimentario (SERIDA), Laboratorio de Sanidad Animal, Jove, Gijón, Asturias 33299, Spain
| | | | | | | | | |
Collapse
|
45
|
Perez V, Romera M, Lizcano JM, Marco JL, Unzeta M. Protective effect of N-(2-propynyl)-2-(5-benzyloxyindolyl) methylamine (PF 9601N), a novel MAO-B inhibitor, on dopamine-lesioned PC12 cultured cells. J Pharm Pharmacol 2003; 55:713-6. [PMID: 12831516 DOI: 10.1211/002235703765344649] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
Oxidative stress may play a role in the pathogenesis of Parkinson's disease. We have standardised a new model of dopaminergic-cell toxicity that uses dopamine, which is able to generate free radicals, as a toxin. The effect of this catecholamine on cell viability (MTT staining) was dose-dependent, reaching 65% of cell loss at a dopamine concentration of 300 microM. In this model, the protective effect of a novel MAO-B inhibitor, N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine (PF 9601N), was studied and compared with the effect of L-deprenyl assayed under the same experimental conditions. Whereas PF 9601N (50 microM and 100 microM) showed a significant protective effect, this was not the case with L-deprenyl. This different behaviour could be explained in terms of difference in antioxidant capacity. The toxicity induced in PC12 cells by 300 microM dopamine was partially reversed by incubating it in the presence of GBR-12909, a dopamine-transporter blocker. The results indicated that, besides the intracellular toxicity effect of dopamine, another non-specific extracellular mechanism could be involved.
Collapse
Affiliation(s)
- V Perez
- Depart. Bioquímica i Biologia Molecular, Fac. Medicina, Universitat Autónoma de Barcelona, Bellaterra 08193, Spain
| | | | | | | | | |
Collapse
|
46
|
Abstract
BACKGROUND Transcranial magnetic stimulation can either excite or inhibit cortical areas of the brain, depending on whether the speed of the repetitive stimulation is applied at high or low frequencies. It has been used for physiological studies and it has also been proposed as a treatment for depression. OBJECTIVES To assess the clinical efficacy and safety of transcranial magnetic stimulation for treating depression. SEARCH STRATEGY An electronic search was performed including the Cochrane Collaboration Depression, Neurosis and Anxiety Review Group trials register (last searched June, 2001), the Cochrane Controlled Trials Register (Issue 2, 2001), MEDLINE (1966-2001), EMBASE (1974-2001), PsycLIT (1980-2001), and bibliographies from reviewed articles. Unpublished data and grey literature were searched through personal communications with researchers. SELECTION CRITERIA Randomised controlled trials assessing the therapeutic efficacy and safety of transcranial magnetic stimulation for depression. DATA COLLECTION AND ANALYSIS All reviewers independently extracted the information and verified it by cross-checking. Disagreements were resolved through discussion. Continuous data: When similar studies were grouped, the overall standardised mean difference was calculated under a fixed effect model weighted by the inverse variance method with 95% confidence intervals. (In the presence of statistical heterogeneity, a random effects model was to be used.) MAIN RESULTS Sixteen trials were included in the review and fourteen contained data in a suitable form for quantitative analysis. Most comparisons did not show differences between rTMS and other interventions. No difference was seen between rTMS and sham TMS using the Beck Depression Inventory or the Hamilton Depression Rating Scale, except for one time period (after two weeks of treatment) for left dorsolateral prefrontal cortex and high frequency; and also for right dorsolateral prefrontal cortex and low frequency, both in favour of rTMS and both using the Hamilton scale. Comparison of rTMS (left dorsolateral prefrontal cortex and high frequency) with electroconvulsive therapy showed no difference except for psychotic patients after two weeks treatment, using the Hamilton scale, which indicated that electroconvulsive therapy was more effective than rTMS. REVIEWER'S CONCLUSIONS The information in this review suggests that there is no strong evidence for benefit from using transcranial magnetic stimulation to treat depression, although the small sample sizes do not exclude the possibility of benefit.
Collapse
Affiliation(s)
- J L Martin
- Iberoamerican Cochrane Centre, Department of Epidemiology, Hospital de la Santa Creu i Sant Pau, Sant Antoni M feminine Claret, 171, Barcelona, Catalunya, Spain, 08041.
| | | | | | | | | | | | | |
Collapse
|
47
|
Catafau AM, Perez V, Gironell A, Martin JC, Kulisevsky J, Estorch M, Carrió I, Alvarez E. SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study. Psychiatry Res 2001; 106:151-60. [PMID: 11382537 DOI: 10.1016/s0925-4927(01)00079-8] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Repetitive transcranial magnetic stimulation (rTMS) is being investigated as an alternative treatment for depression. However, little is known about the clinical role and the neurophysiological mechanisms of the action of rTMS in these patients. In this study, 99mTc-HMPAO single photon emission computed tomography (SPECT) was used to map the effects of left dorsolateral prefrontal rTMS on prefrontal activity in seven patients who met DSM-IV criteria for major depression resistant to pharmacological treatment. rTMS consisted of 30 trains of 2-s duration stimuli (20 Hz, 90% of motor threshold), separated by 30-s pauses. Each patient underwent three SPECTs: at baseline; during the first rTMS; and 1 week after 10 daily sessions of rTMS. Regional cerebral blood flow (rCBF) of each cerebral region was normalized to the rCBF value in the cerebellum and relative changes in normalized rCBF were addressed using a region-of-interest analysis. The Hamilton Depression Rating Scale (HDRS) was used for clinical evaluation before and after rTMS. A significant rCBF increase after the 10 sessions of rTMS was found in the left prefrontal region (MANOVA F=5.29, d.f.=2,10, P=0.027), but no significant rCBF changes were found during the first rTMS session. The remaining cerebral regions showed no significant rCBF changes at any time. Only two patients showed a clinical improvement after rTMS, with 50% reduction of the initial HDRS score. The study was repeated under placebo conditions (identical design but addressing coil discharges to the air) in these two patients, who failed to show any rCBF increase during sham-rTMS. No relationship was found between the percentage of left prefrontal rCBF change and the clinical findings. In conclusion, rTMS of the left prefrontal cortex induces a significant rCBF increase in this region, despite the limited clinical effect in our sample of depressed patients. Cerebral perfusion SPECT is a useful tool to map cerebral activity changes induced by rTMS.
Collapse
Affiliation(s)
- A M Catafau
- Nuclear Medicine Department, Hospital de Sant Pau, Pare Claret 167, 08025, Barcelona, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Collantes E, Veroz R, Escudero A, Muñoz E, Muñoz MC, Cisnal A, Perez V. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine 2001; 67:516-20. [PMID: 11195314 DOI: 10.1016/s1297-319x(00)00201-3] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVES When evaluating patients for spondyloarthropathy, clinicians use the 'possible spondyloarthropathy' category to indicate that they are unsure about the diagnosis. We sought to determine whether Amor's criteria or the European Spondyloarthropathy Study Group (ESSG) criteria could lift thi uncertainty. PATIENTS AND METHODS During a Spanish study designed to validate criteria for spondyloar thropathies, 102 patients were classified in the 'possible spondyloarthropathy' category. We divided these patients into subgroups based on whether or not they met criteria for spondyloarthropathy. We compare baseline characteristics (N = 102) and five-year outcomes (N = 52) in these subgroups. RESULTS The following features were significantly more common in the subgroups of patients who met Amor's criteria for spondyloarthropathy: oligoarthritis, heel pain, uveitis, balanitis, family history of spondyloarthropathy, an presence of the HLA B27 antigen. No differences were found for age at symptom onset, disease duration, buttock pain, gender, dactylitis, diarrhea, or psoriasis. Of the 52 patients followed up for five years, 17 me Amor's criteria at baseline and 13 were subsequently found to have definite spondyloarthropathy, whic was undifferentiated in six cases. There were only three cases of spondyloarthropathy among the 2 patients who did not meet Amor's criteria at baseline. Of the 28 patients who met ESSG criteria at baseline, 13 had spondyloarthropathy versus three of the 17 patients who did not meet ESSG criteria at baseline CONCLUSION Amor's criteria or the ESSG criteria allow early classification of most patients with 'possible spondyloarthropathy' and early identification of undifferentiated spondyloarthropathy corresponding to minimal-symptom or incipient disease. In this study, Amor's criteria performed better than the ESSG criteria.
Collapse
Affiliation(s)
- E Collantes
- Service de rhumatologie, hopital universitaire Reina Sofía, département de médecine, université de Cordoue, Córdoba, Spain
| | | | | | | | | | | | | |
Collapse
|
49
|
Corpa JM, Juste RA, Marin JFG, Reyes E, Gonzalez J, Perez V. Distribution of Lymphocyte Subsets in the Small Intestine Lymphoid Tissue of 1-Month-Old Lambs. Anat Histol Embryol 2001. [DOI: 10.1046/j.1439-0264.2001.00312.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
50
|
Ferreras MC, Gonzalez J, Perez V, Reyes LE, Gomez N, Perez C, Corpa JM, Garcia-Marin JF. Proximal Aortic Dissection (Dissecting Aortic Aneurysm) in a Mature Ostrich. Avian Dis 2001. [DOI: 10.2307/1593037] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|